Specific code 2014 ICD-9-CM Diagnosis Code 207.82
Other specified leukemia, in relapse
  • 2014
  • Billable Thru Sept 30/2015
  • Non-Billable On/After Oct 1/2015

  • Short description: Oth spf leuk in relapse.
  • ICD-9-CM 207.82 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 207.82 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
  • You are viewing the 2014 version of ICD-9-CM 207.82.
  • More recent version(s) of ICD-9-CM 207.82: 2015.
Convert to ICD-10-CM: 207.82 converts approximately to:
  • 2015/16 ICD-10-CM C94.32 Mast cell leukemia, in relapse
    Or:
  • 2015/16 ICD-10-CM C94.82 Other specified leukemias, in relapse
Approximate Synonyms
  • Leukemia, lymphosarcoma cell in relapse
  • Leukemia, mast cell, in relapse
  • Lymphosarcoma cell leukemia in relapse
  • Lymphosarcoma cell leukemia, in relapse
  • Mast cell leukemia in relapse
  • Mast cell leukemia, in relapse
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 207.82 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2014 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.